Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts.
about
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor ImmunityRetargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR".CAR T-Cell Therapy: Progress and Prospects.Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL.Prospects for combined use of oncolytic viruses and CAR T-cells.Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation.Advances in immunotherapy for pediatric acute myeloid leukemia.Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies.Chimeric antigen receptor transduced T cells: Tuning up for the next generation.Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells.Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells.Engineering a Dual Small Molecule Gated ZAP70 Switch in T Cells.The development of CAR design for tumor CAR-T cell therapy.A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform.From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo.Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model.Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
P2860
Q33700795-01024EA2-C5CB-488C-8DDD-90A0193EA6CEQ33761755-CA549008-5D88-4664-9691-38C3CDE16821Q38741433-1216265A-038D-4330-B6EB-64DC4E03F54CQ45872592-026BF713-8737-47A7-A400-9A2029A66D5AQ46082373-6B206246-15D6-4946-B7F6-40BD823B7B36Q47103891-6E1C4F9E-1767-4E3C-BE81-3F90F542A1ACQ47566513-B2288009-0DDF-4254-9AED-C77264F0F068Q47930962-37B7DB93-A0C2-4CB1-99B7-21CA94C2A7F0Q48255324-2B2AECA2-CA09-481D-8559-1D585B15ADFDQ48337005-D6B1CF63-F3A0-42E1-94C6-B546447C9C66Q49210694-3E31BE86-0A82-40B9-9BB2-6C4C7E7302F6Q50315378-9DDF43E0-3048-482F-8C09-CD1022A23BF4Q52625841-AB2FFDB6-B26C-47B7-8290-AD0683AFB7CFQ52641562-3626604E-B89B-4BF6-BD56-6FEFF3C75E1AQ54945917-239C2B32-04AA-43E2-B881-B621CB6C1ED7Q55093479-59214099-B350-4A50-B9E1-76F4C4E02200Q55292778-6D7A47C3-CDB9-4E3C-9370-D35DE6C50E1CQ55322285-224794CE-9862-4919-9A7B-84D2DD8716AAQ58718475-692D7C0A-C7E6-4B50-AF37-D2947D8218DE
P2860
Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Switching CAR T cells on and o ...... ting of T cells to AML blasts.
@en
type
label
Switching CAR T cells on and o ...... ting of T cells to AML blasts.
@en
prefLabel
Switching CAR T cells on and o ...... ting of T cells to AML blasts.
@en
P2093
P2860
P356
P1433
P1476
Switching CAR T cells on and o ...... ting of T cells to AML blasts.
@en
P2093
A Ehninger
A Feldmann
E P Bejestani
G Ehninger
M von Bonin
S Koristka
P2860
P2888
P356
10.1038/BCJ.2016.61
P577
2016-08-12T00:00:00Z
P6179
1040037504